The DOI matches its Crossref record, with a small difference in title or year; 16 of the 16 references it cites were found in a registry or an index.
Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ‐interferon: Association with a coordinate decrease in types I and III procollagen messenger RNA levels
Abstract
The effects of recombinant γ‐interferon (rec γ‐IFN) on collagen production by confluent monolayer cultures of progressive systemic sclerosis (PSS) dermal fibroblasts were studied. Five cell lines obtained from patients with rapidly progressive disease of recent onset were examined. All PSS fibroblast cell lines exhibited increased collagen production when compared with normal skin cell lines. It was found that rec γ‐IFN caused potent inhibition of PSS fibroblast collagen production in a concentration‐dependent manner. Greater than 50% inhibition was observed with as little as 50 antiviral units/ml, and maximal effects were attained at a concentration of 500 units/ml. The rec γ‐IFN caused reproducible inhibition of collagen production by the 5 PSS fibroblast cell lines, ranging from 58.9% to 85.6% of control values. Measurement of type I and type III procollagen messenger RNA (mRNA) levels with specific complementary DNA probes demonstrated a coordinate reduction of >60% in mRNA for both transcripts in rec γ‐IFN‐treated cells, compared with control cells. These findings indicate that rec γ‐IFN can modulate the excessive collagen biosynthesis characteristic of PSS fibroblasts and that this effect can be explained largely by the γ‐IFN‐mediated decrease in specific collagen mRNAs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, interferon γ (IFNγ) inhibits collagen synthesis, sensitizes dermal fibroblast to Fas-mediated apoptosis (125, 126) and inhibits IL-4 effects (125).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [126]
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Kafatos, F. C., Jones, C. W., & Efstratiadis, A. (1979) · Nucleic Acids Research · doi:10.1093/nar/7.6.1541 · Cited by 1,360
Modified procedure for the assay of H3- or C14-labeled hydroxyproline
Juva, K., & Prockop, D. J. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90249-1 · Cited by 702
Chu, M.-L., Myers, J. C., Bernard, M. P., Ding, J.-F., & Ramirez, F. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.19.5925 · Cited by 492
Convenient assay for interferons
Rubinstein, S., Familletti, P. C., & Pestka, S. (1981) · Journal of Virology · doi:10.1128/jvi.37.2.755-758.1981 · Cited by 481
Selective inhibition of human diploid fibroblast collagen synthesis by interferons.
Jimenez, S. A., Freundlich, B., & Rosenbloom, J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111480 · Cited by 329
Self-citationDuncan, M. R., & Berman, B. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.2.516 · Cited by 272
Cloning a cDNA for the pro-alpha 2 chain of human type I collagen.
Myers, J. C., Chu, M. L., Faro, S. H., Clark, W. J., Prockop, D. J., & Ramirez, F. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3516 · Cited by 190
Arey, L. B. (1936) · Physiological Reviews · doi:10.1152/physrev.1936.16.3.327 · Cited by 165
Inhibition of collagen synthesis by mononuclear cell supernates.
Jiménez, S. A., McArthur, W. P., & Rosenbloom, J. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.150.6.1421 · Cited by 141
Self-citation
Research works printed but not linked: 3
- Leroy EC, 1985, Scleroderma (systemic sclerosis), Textbook of Rheumatology, 1183
- Brouty‐Boye D, 1980, Inhibitory effects of interferons on cell multiplication, Lymphokine Res, 1, 99
- Maniatis T, 1982, Molecular Cloning, 196
Cited by
Dinarello, C. A., & Mier, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171506 · Cited by 463
Pathogenesis of Systemic Sclerosis
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 405
Haverty, T. P., Kelly, C. J., Hines, W. H., Amenta, P. S., Watanabe, M., Harper, R. A., Kefalides, N. A., & Neilson, E. G. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1359 · Cited by 306
Rook, A. H., Freundlich, B., Jegasothy, B. V., Perez, M. I., Barr, W. G., Jimenez, S. A., Rietschel, R. L., Wintroub, B., Kahaleh, M. B., & Varga, J. (1992) · Archives of Dermatology · doi:10.1001/archderm.1992.01680130051005 · Cited by 299
Self-citationNovel therapeutic approaches for pulmonary fibrosis
Datta, A., Scotton, C. J., & Chambers, R. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01247.x · Cited by 202
Metadata
- Authors
- Rosenbloom, J., Feldman, G., Freundlich, B., & Jimenez, S. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1986-07
- Volume
- 29
- Issue
- 7
- Pages
- 851-856
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2034254900
- Cited by
- 101
- References
- 16
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 3
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2r01am019616-08)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Keywords
- interferon-gamma, systemic sclerosis, dermal fibroblasts, collagen synthesis, type I procollagen, type III procollagen, procollagen mRNA, antifibrotic therapy
- MeSH terms
- Adult, Cell Line, Collagen, Dose-Response Relationship, Drug, Female, Fibroblasts, Humans, Interferon-gamma, Male, Middle Aged, Nucleic Acid Hybridization, Procollagen, Recombinant Proteins, RNA, Messenger, Scleroderma, Systemic, Skin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ‐interferon: Association with a coordinate decrease in types I and III procollagen messenger RNA levels. https://app.cochat.ai/papers/10.1002/art.1780290706
- The paper
- Rosenbloom, J., Feldman, G., Freundlich, B., & Jimenez, S. A. (1986). Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ‐interferon: Association with a coordinate decrease in types I and III procollagen messenger RNA levels. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780290706
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.